In an important discovery for the next-generation of malaria vaccines, University of Oxford researchers in the Department of Paediatrics, in collaboration with the Scripps Institute, have identified how antibodies can be over 90% effective at preventing malaria parasites from growing in certain combinations.
The winners of the 2026 Vice-Chancellor\u2019s Awards were announced at a special ceremony hosted by the Vice-Chancellor in the Schwarzman\u2019s Sohmen Concert Hall on Thursday 4 June.
Leading experts from the University of Oxford and the World Health Organization are calling on the global community to invest in affordable proven solutions and change policy to end preventable deaths from bleeding during childbirth.
A major new research programme, led by Professor Ruth Travis and Dr Karl Smith-Byrne (Nuffield Department of Population Health) and funded by Cancer Research UK, aims to uncover the biological causes of prostate cancer and identify ways to prevent the disease. The programme is being delivered through a collaboration between researchers in the Nuffield Department of Population Health and the Nuffield Department of Surgical Sciences (NDS).
Scientists have identified the missing link between a long-known genetic signal in inflammatory bowel disease and a damaging immune response that switches off the body\u2019s natural control of inflammation - opening the door to faster diagnosis and targeted treatment.
Researchers from the Department of Pharmacology have found that the \u2018neural compass\u2019 that enables mice to navigate is formed of specialised brain cells that respond in different ways to stimuli such as light and sound.
Oxford researchers will test an AI-powered triage system that draws on patients' medical histories to help GP teams prioritise urgent same-day care. The project is funded by the NIHR as part of an \u00a38.1 million investment in digital technologies to reduce NHS waiting times.
Phase 1 of the INTERCEPT-Lynch trial, which is funded by Moderna, sponsored by the University of Oxford and run by the University's Oncology Clinical Trials Office with support from Oxford Cancer, has received authorisation from the Medicines and Healthcare products Regulatory Agency and is expected to begin recruiting participants this summer.
Professor Gaia Scerif from the Department of Experimental Psychology is a key partner in a newly announced research centre that will help shape education policy across England.
Professor Marian Knight, Director of the National Perinatal Epidemiology Unit (NPEU), appeared on BBC Breakfast on 5th June to discuss new NPEU research examining recent changes in caesarean birth rates in England.
Professor Emma Slack, Professor of Molecular Immunology, at the Dunn School and collaborators have developed a preventive approach that stops harmful bacteria in their tracks before transmission even occurs.
A new opinion article published in Trends in Cell Biology explores how tiny packages released by cells, known as exosomes, could help researchers better understand disease and may one day support new approaches to diagnosis and treatment.
Researchers from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) are playing leading roles in a major new UK-wide research consortium aiming to improve treatment and outcomes for people living with osteoarthritis.
Researchers from the Ineos Oxford Institute for antimicrobial research (IOI) have identified a new class of molecule that could help protect \u2018last-resort\u2019 antibiotics from bacterial resistance, and reduce the amount of antibiotics needed to treat infections by up to 32 times.
A major international study led by researchers at the Kennedy Institute of Rheumatology at the University of Oxford has found that osteoarthritis (OA) \u2013 the most common form of arthritis worldwide \u2013 is not a collection of separate diseases, as many scientists had previously speculated, but rather a single condition with common core underlying biological pathways.
A new study from the University of Oxford and le Centre National de la Recherche Scientifique (CNRS) has shown that the brain uses rhythms for brain cell impulses to coordinate activity across memory-related regions in the brain during learning and help reactivate those experiences afterwards, strengthening what we remember.
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced today that it will urgently accelerate the development of three investigational vaccines targeting the Bundibugyo ebolavirus that has caused a rapidly spreading epidemic in the Democratic Republic of the Congo (DRC) and neighbouring Uganda, including one being developed by the Oxford Vaccine Group at the University of Oxford.
A new partnership will unite expertise, infrastructure and data across borders to accelerate diagnosis, treatment and ultimately prevention of major diseases \u2013 starting with women\u2019s health, infectious diseases and pandemic preparedness.
The Department of Paediatrics at the University of Oxford today announces the launch of Genes, Brains, and Breakthroughs, a new educational campaign designed to raise public awareness and understanding of neurodevelopmental disorders through a series of accessible, family-informed video resources.
Researchers have discovered that some human blood stem cells retain a lasting \u201cmemory\u201d of inflammation, a finding that could help explain links between ageing, chronic disease, and blood cancers
![\"RIPR](\"https://www.medsci.ox.ac.uk/news/paediatrics-scientists-discover-antibody-combinations-that-block-over-90-of-malaria-parasite-growth/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n